SAR - Phytopharm PLC
09 Mayo 2003 - 6:49AM
UK Regulatory
RNS Number:9123K
Amvescap PLC
09 May 2003
FORM SAR 3
Lodge with Company Announcements Office and the Panel. A copy must also be sent to the company the
shares of which are acquired.
Date of disclosure 9 MAY 2003
DISCLOSURE UNDER RULE 3 OF THE RULES GOVERNING
SUBSTANTIAL ACQUISITIONS OF SHARES ("SARs")
Date of acquisition 8 MAY 2003
Acquisition in ........ PHYTOPHARM PLC ...... (name of company)
(1) Class of voting shares Number of shares/rights If rights over shares
(eg ordinary shares) over shares acquired acquired, as opposed
to the shares
themselves, specify
nature of rights
ORDINARY 1P 70,000 shares -
- N/A rights -
(2) Resultant total holding Resultant total holding Total percentage
of voting shares (and % of rights over shares
of total voting shares (and % of total voting
in issue) shares in issue)
8,520,434 (22.04%) - 8,520,434 (22.04%)
(3) Party making disclosure................ AMVESCAP PLC ..................
(4) (a) Name of person acquiring shares or rights over shares DISCRETIONARY MANAGED CLIENTS OF AMVESCAP
and, if different, beneficial owner ................................
(b) Names of any other persons acting by
agreement or understanding (see SAR 5)............................
Signed, for and on behalf of the party named in (3) above........R CLYDE.....
(Also print name of signatory)............ROBERT CLYDE.......................
Telephone and extension number............020 7065 3720......................
Note. Under SAR 5, the holdings of and acquisitions by persons acting by
agreement or understanding must be aggregated and treated as a holding of or
acquisition by one person. Note 3 on SAR 5 requires persons who must aggregate
holdings to disclose certain disposals.
For full details of the SARs disclosure requirements, see Rules 3 and 5 of the
SARs. If in doubt, contact the Panel on Takeovers and Mergers, Monitoring
Section, Tel. No: 020 7638 0129. Email:monitoring@disclosure.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
SADNKCKQDBKDFPK_SN_RNS9123K_SU_RNSTEST_XX_114929.9507_RZ__RT_R.xRoute.000
~